EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophrenia

Ricardo Twumasi iD, Frederikke Hørdam Gronemann iD, Carsten Hjorthøj iD, Oliver Howes iD, Maximin Lange iD, Merete Nordentoft iD, Merete Osler iD

Psychological Medicine · 2026

DOI: 10.1017/s0033291726104693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychological Medicine, 2026. Verfasst von Ricardo Twumasi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK. Hauptthemen laut MEDLINE: Antipsychotic Agents, Schizophrenia, Employment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: Medical Research Council, NIHR Maudsley Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antipsychotic medications are recommended for schizophrenia spectrum disorders, yet their long-term effects on functional recovery remain unclear, with conflicting evidence often derived from between-subject comparisons vulnerable to confounding by indication.

Methods

We conducted a nationwide register-based cohort study of 65,630 individuals with incident schizophrenia spectrum disorders in Denmark (1998–2023). We modeled antipsychotic exposure against ‘productive engagement’ (employment or education). We used two analytical approaches: (1) within-subject stratified Cox models with time-varying covariates to eliminate time-invariant confounding; and (2) Fine–Gray competing risks models with baseline exposure, accounting for mortality and emigration.

Results

Over 26.9 million person-weeks, the overall productive engagement rate was 48.2%. Integration of hospital pharmacy data revealed 6.1% exposure misclassification in studies relying solely on community records. The primary within-subject analysis revealed significant temporal heterogeneity: medication use was associated with reduced engagement rates in the acute (0–2 years; HR = 0.908) and consolidation phases (2–5 years; HR = 0.946), but reversed to a small positive association in the maintenance phase (5+ years; HR = 1.019). The between-subject Fine–Gray model, which estimates cumulative engagement probabilities, yielded an SHR of 1.002 (95% CI = 0.988–1.015), a population-level average that obscured these phase-specific dynamics.

Conclusions

Antipsychotic pharmacotherapy exerts a time-dependent, biphasic impact on vocational recovery. We identified a window of vulnerability during the post-acute ‘consolidation’ phase (years 2–5) where treatment is associated with a transient reduction in productive engagement, before becoming protective after 5 years. These findings challenge the assumption that symptomatic stability automatically facilitates functional reintegration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsSchizophreniaEmploymentHumansDenmarkFemaleAdultRegistriesMaleCohort StudiesMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

big datafunctional outcomesompeting riskspsychosisregistryskizofreniwithin-subject design

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
  • Copenhagen Research Centre for Mental Health (CORE), Bispebjerg and Freriksberg Hospital, Copenhagen, Denmark.
  • Center for Clinical Research and Prevention, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
  • Department of Public Health, Faculty of Health Sciences, University of Copenhagen Denmark.
  • South London and Maudsley NHS Foundation Trust, London, UK.
  • Department for Clinical Medicine, Faculty of Health Science, University of Copenhagen, Denmark.

ORCID-Profile: Ricardo Twumasi, Frederikke Hørdam Gronemann, Carsten Hjorthøj, Oliver Howes, Maximin Lange, Merete Nordentoft, Merete Osler

Förderung

  • Medical Research Council
  • NIHR Maudsley Biomedical Research Centre

Zitieren

APA

Twumasi, R., Gronemann, F. H., Hjorthøj, C., Howes, O., Lange, M., Nordentoft, M., & Osler, M. (2026). Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophrenia. Psychological Medicine. https://doi.org/10.1017/s0033291726104693

Vancouver

Twumasi R, Gronemann FH, Hjorthøj C, Howes O, Lange M, Nordentoft M, et al. Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophrenia. Psychological Medicine. 2026. doi:10.1017/s0033291726104693

BibTeX
@article{Twumasi2026,
  author = {Twumasi, Ricardo and Gronemann, Frederikke Hørdam and Hjorthøj, Carsten and Howes, Oliver and Lange, Maximin and Nordentoft, Merete and Osler, Merete},
  title = {Real-world effectiveness of antipsychotic treatment of functional outcomes over 10 years: A national cohort of patients in Denmark with schizophrenia},
  journal = {Psychological Medicine},
  year = {2026},
  doi = {10.1017/s0033291726104693}
}
Kostenlos starten →